The Application of Multimodal Ultrasound Imaging in Carpal Tunnel Syndrome
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Carpal Tunnel Syndrome (CTS)
- Sponsor
- The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
- Enrollment
- 40
- Primary Endpoint
- Boston Carpal Tunnel Syndrome Questionnaire ，BCTQ
- Status
- Not yet recruiting
- Last Updated
- last year
Overview
Brief Summary
The aim of this study is to explore the application value of multimodal ultrasound parameters in the diagnosis and treatment follow-up of Carpal Tunnel Syndrome.
Investigators
Dr. weijing zhang
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Eligibility Criteria
Inclusion Criteria
- •Age between 18 and 70 years;
- •Presence of sensory abnormalities and motor dysfunction in the median nerve distribution area;
- •Positive Tinel's sign or Phalen's test;
- •Neurophysiological examination consistent with mild to moderate Carpal Tunnel Syndrome.-
Exclusion Criteria
- •Severe Carpal Tunnel Syndrome;
- •Concurrent rheumatic, metabolic, systemic, or other systemic diseases;
- •Concurrent cervical spondylosis or other peripheral neuropathies;
- •Wrist joint trauma, surgery, space-occupying lesions, or nerve itself with space-occupying lesions;
- •Concurrent malignant tumors or severe cardiopulmonary diseases;
- •History of previous wrist surgery or injections;
- •Allergy to corticosteroids or local anesthetics.-
Outcomes
Primary Outcomes
Boston Carpal Tunnel Syndrome Questionnaire ，BCTQ
Time Frame: 1,3,6,12 months
The Boston Carpal Tunnel Score is a patient-reported questionnaire that examines symptom severity and overall functional status of patients with carpal tunnel syndrome. The Symptom Severity Scale (SSS) with 11 questions is scored on a Likert scale of 1-5 and the Functional Status Scale (FSS) with 8 questions is scored from 1-5 with 1 as no difficulty and 5 as difficult.The higher scores mean a worse outcome.
Secondary Outcomes
- the patient's sensory nerve conduction velocity (SNCV)(3,6,12months)
- the patient's distal motor latency (DML).(3,6,12months)